Pharmaceuticals
Valeant tables hostile $45.7 bn bid for Botox maker Allergan
23 Apr 2014
Valeant Pharmaceuticals International Inc, Canada's biggest drug maker and one of the most aggressive acquirers, yesterday tabled a hostile $45.7-billion cash and stock bid for Botox maker Allergan Inc
Novartis AG, GSK in $23-bn assets swap deal
22 Apr 2014
Swiss drug giant Novartis AG and Britain's GlaxoSmithKline Plc (GSK) today announced a swap of assets in a deal valued at around $23 billion
Eli Lilly to buy Novartis AG's animal health business for $5.4 bn
22 Apr 2014
Eli Lilly and Co today struck a deal to buy Swiss drugmaker Novartis AG's animal health business for $5.4 billion in cash in order to strengthen and diversify its own animal health business, Elanco.
Valeant teams up with hedge fund to buy Botox maker Allergan for $42 bn
22 Apr 2014
News of the impending bid sent the stock price of Valeant and Allergan companies soaring in after-hours trading
Pfizer weighs $101-bn bid for AstraZeneca
21 Apr 2014
A potential deal with AstraZeneca would be the biggest-ever acquisition in the pharmaceutical industry, and would see another iconic British brand being acquired by a foreign company
Glenmark recalls anti-ulcer drug in the US over tablet mix-up
19 Apr 2014
Glenmark Pharmaceuticals Ltd is recalling 2,900 bottles of its anti-ulcer drug ranitidine from the US market after a tablet to treat high blood pressure was found in one of the bottles
